Flavocure Biotech, Inc. Announces a New Appointment to the Advisory Board

Baltimore, Maryland–(Newsfile Corp. – June 7, 2021) – The Board and Management of Flavocure Biotech, Inc. (“Flavocure”) a drug discovery and development company, announced today the appointment of Dr Thomas F. Woolf, PhD, an expert in pharmaceutical sciences to the company’s Board of Advisors.

Read More about this Press Release on BIOSPACE.COM

One Response

Recent News

News Categories

Never miss any important news. Subscribe to our newsletter.

Related Posts

Join our Mailing list!

Get all latest news from Flavocure Biotech